How Much Does Lipitor Lower Cholesterol on Average?
Regular use of Lipitor (atorvastatin), typically 10-80 mg daily, reduces LDL cholesterol by 35-60% from baseline, depending on dose and patient factors like starting levels. A 20 mg dose, common for moderate cases, averages 40-50% LDL reduction; 40 mg often hits 50-55%; higher doses push toward 60%.[1][2]
For total cholesterol, expect 25-40% drops. HDL rises 5-10%, and triglycerides fall 20-40%.[1]
What Clinical Trials Show for LDL Drops
The landmark ASCOT-LLA trial (10,305 patients, 10 mg Lipitor) saw LDL fall 35% on average vs. placebo, from 131 mg/dL to 85 mg/dL.[3] CURVES trial compared doses: 10 mg dropped LDL 38%; 20 mg, 46%; 40 mg, 51%; 80 mg, 57%.[2] Real-world data aligns, with meta-analyses confirming 40-50% average LDL reduction at standard doses.[1]
Factors Affecting Your Cholesterol Drop
Higher starting LDL predicts bigger absolute drops—patients over 190 mg/dL see more than those under 130 mg/dL. Diet, exercise, genetics, and statins like Lipitor work together; adding fiber or ezetimibe boosts reductions 10-15%.[4] Women and Asians often get slightly larger drops than men or Caucasians.[1]
Age matters: under-65s average 45% LDL drop; over-65s closer to 40% due to slower metabolism.[2]
Time to See Results and Peak Effect
LDL drops 20-30% within 2 weeks, maxing at 4-6 weeks. Full effects stabilize by 8 weeks. Stopping reverses gains in 2-4 weeks.[1][5]
Lipitor vs. Other Statins: Which Drops More?
Lipitor outperforms simvastatin (Zocor, 30-45% LDL drop) and pravastatin (Pravachol, 25-35%) at equivalent doses, matching high-potency rosuvastatin (Crestor) at 20-40 mg.[2][6] Generic atorvastatin costs $10-20/month vs. Crestor's $300+.
| Statin (20 mg dose) | Avg. LDL Drop |
|---------------------|---------------|
| Atorvastatin (Lipitor) | 45-50% [2] |
| Rosuvastatin (Crestor) | 50-55% [6] |
| Simvastatin (Zocor) | 35-40% [2] |
Side Effects Tied to Cholesterol Goals
Muscle pain hits 5-10% (dose-related; lower at 10-20 mg), rarely rhabdomyolysis (<0.1%). Liver enzyme rises in 1-3%; monitor first year. No direct link to bigger drops increasing risks—benefits outweigh for high-risk patients.[1][7]
When Does Lipitor's Patent Expire (Generics Timeline)?
Lipitor's main U.S. patents expired November 2011; generics captured 90% market share by 2013, dropping prices 80%+. No active exclusivities block biosimilars (it's synthetic).[8]
[1]: Drugs.com - Lipitor
[2]: DrugPatentWatch.com - Atorvastatin
[3]: NEJM - ASCOT-LLA
[4]: AHA Guidelines
[5]: Pfizer Lipitor Prescribing Info
[6]: JAMA Meta-Analysis Statins
[7]: FDA Statin Safety
[8]: DrugPatentWatch.com - Lipitor Patents